AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 41 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $19,000 | -5.0% | 128,000 | 0.0% | 0.01% | +8.3% |
| Q2 2019 | $20,000 | -20.0% | 128,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $25,000 | -72.2% | 128,000 | 0.0% | 0.02% | -81.2% |
| Q4 2018 | $90,000 | -42.7% | 128,000 | 0.0% | 0.08% | -15.8% |
| Q3 2018 | $157,000 | +10.6% | 128,000 | 0.0% | 0.10% | +4.1% |
| Q2 2018 | $142,000 | -44.7% | 128,000 | 0.0% | 0.10% | -42.6% |
| Q1 2018 | $257,000 | +66.9% | 128,000 | 0.0% | 0.17% | +87.8% |
| Q4 2017 | $154,000 | -4.3% | 128,000 | 0.0% | 0.09% | +8.4% |
| Q3 2017 | $161,000 | -5.3% | 128,000 | 0.0% | 0.08% | -7.8% |
| Q2 2017 | $170,000 | +34.9% | 128,000 | +88.2% | 0.09% | +28.6% |
| Q1 2017 | $126,000 | -49.4% | 68,000 | +41.7% | 0.07% | -54.2% |
| Q4 2016 | $249,000 | – | 48,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $142,000 | 0.10% |
| Baker Brothers Advisors | 4,055,142 | $4,501,000 | 0.03% |
| WEDBUSH SECURITIES INC | 209,524 | $233,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,105,000 | 0.01% |
| Verity Asset Management, Inc. | 11,500 | $13,000 | 0.01% |
| OneDigital Investment Advisors LLC | 11,437 | $13,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $17,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 120,619 | $134,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $3,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $2,000 | 0.00% |